0

Journal Articles

in Cardiovascular Disease Prevention
 1-20 of 104 Articles
Original Contribution |  June 12, 2013
Clinical Ascertainment of Health Outcomes Among Adults Treated for Childhood Cancer
Melissa M. Hudson, MD; Kirsten K. Ness, PT, PhD; James G. Gurney, PhD; et al.
JAMA. 2013;309(22):2371-2381. doi:10.1001/jama.2013.6296.
INCLUDES: CME , Supplemental Content
Original Contribution |  May 15, 2013
Association of Single- vs Dual-Chamber ICDs With Mortality, Readmissions, and Complications Among Patients Receiving an ICD for Primary Prevention
Pamela N. Peterson, MD, MSPH; Paul D. Varosy, MD; Paul A. Heidenreich, MD; et al.
JAMA. 2013;309(19):2025-2034. doi:10.1001/jama.2013.4982.
INCLUDES: , Supplemental Content
Original Contribution |  May 08, 2013
Effect of Long-Detection Interval vs Standard-Detection Interval for Implantable Cardioverter-Defibrillators on Antitachycardia Pacing and Shock Delivery:  The ADVANCE III Randomized Clinical Trial
Maurizio Gasparini, MD; Alessandro Proclemer, MD; Catherine Klersy, MD, MSc; et al.
JAMA. 2013;309(18):1903-1911. doi:10.1001/jama.2013.4598.
INCLUDES: , Supplemental Content
Viewpoint |  April 17, 2013
Combination Therapy to Prevent Cardiovascular Disease:  Slow Progress
Richard Smith, MB, ChB, MSc, FRCPE; Tara McCready, MBA, PhD; Salim Yusuf, DPhil, FRCPC, FRSC
JAMA. 2013;309(15):1595-1596. doi:10.1001/jama.2013.3180.
Original Contribution |  April 17, 2013
Prevalence of a Healthy Lifestyle Among Individuals With Cardiovascular Disease in High-, Middle- and Low-Income Countries:  The Prospective Urban Rural Epidemiology (PURE) Study
Koon Teo, MB, PhD; Scott Lear, PhD; Shofiqul Islam, MSc; et al.
JAMA. 2013;309(15):1613-1621. doi:10.1001/jama.2013.3519.
INCLUDES: , Supplemental Content
JAMA Patient Page |  April 17, 2013 FREE
Aspirin Therapy
Janet M. Torpy, MD; Edward H. Livingston, MD
JAMA. 2013;309(15):1645. doi:10.1001/jama.2013.3866.
INCLUDES: , Supplemental Content
Lab Reports |  April 03, 2013
Age-Dependent Heart Damage
Tracy Hampton, PhD
JAMA. 2013;309(13):1337. doi:10.1001/jama.2013.3157.
JAMA Patient Page |  April 03, 2013 FREE
Statins
Deborah Tolmach Sugerman, MSW; Edward H. Livingston, MD; Cassio Lynm, MA
JAMA. 2013;309(13):1419. doi:10.1001/jama.2013.3041.
INCLUDES: , Supplemental Content
Editorial |  March 27, 2013 FREE
Concerns About Reliability in the Trial to Assess Chelation Therapy (TACT)
Steven E. Nissen, MD
JAMA. 2013;309(12):1293-1294. doi:10.1001/jama.2013.2778.
Editorial |  March 27, 2013 FREE
Evaluation of the Trial to Assess Chelation Therapy (TACT):  The Scientific Process, Peer Review, and Editorial Scrutiny
Howard Bauchner, MD; Phil B. Fontanarosa, MD, MBA; Robert M. Golub, MD
JAMA. 2013;309(12):1291-1292. doi:10.1001/jama.2013.2761.
INCLUDES: , Supplemental Content
From the Centers for Disease Control and Prevention |  March 27, 2013 FREE
CDC Grand Rounds: The Million Hearts Initiative
JAMA. 2013;309(12):1221-1223. doi:10.1001/jama.2013.221.
Viewpoint |  March 20, 2013
Improving Cardiovascular Health:  A Balance Between Discovery and Delivery
William A. Zoghbi, MD; David R. Holmes, MD
JAMA. 2013;309(11):1117-1118. doi:10.1001/jama.2013.2416.
Editorial |  March 13, 2013
Should Clinicians Encourage Smoking Cessation for Every Patient Who Smokes?
Michael C. Fiore, MD, MPH, MBA; Timothy B. Baker, PhD
JAMA. 2013;309(10):1032-1033. doi:10.1001/jama.2013.1793.
Original Contribution |  March 13, 2013
Association of Smoking Cessation and Weight Change With Cardiovascular Disease Among Adults With and Without Diabetes
Carole Clair, MD, MSc; Nancy A. Rigotti, MD; Bianca Porneala, MS; et al.
JAMA. 2013;309(10):1014-1021. doi:10.1001/jama.2013.1644.
INCLUDES: CME , Supplemental Content
JAMA Clinical Evidence Synopsis |  March 06, 2013
Antiplatelet Therapy to Prevent Cardiovascular Events and Mortality in Patients With Intermittent Claudication
Peng Foo Wong, MD, FRCS (Gen); Lee-Yee Chong, BSc, PhD; Gerard Stansby, MChir, FRCS
JAMA. 2013;309(9):926-927. doi:10.1001/jama.2013.1490.
Viewpoint |  January 09, 2013
Physical Activity and Structured Exercise for Patients With Stable Ischemic Heart Disease
William E. Boden, MD; Barry A. Franklin, PhD; Nanette K. Wenger, MD
JAMA. 2013;309(2):143-144. doi:10.1001/jama.2012.128367.
Original Contribution |  January 02, 2013
Survival of Patients Receiving a Primary Prevention Implantable Cardioverter-Defibrillator in Clinical Practice vs Clinical Trials
Sana M. Al-Khatib, MD, MHS; Anne Hellkamp, MS; Gust H. Bardy, MD; et al.
JAMA. 2013;309(1):55-62. doi:10.1001/jama.2012.157182.
INCLUDES: , Supplemental Content
Editorial |  December 26, 2012
Combating the Epidemic of Heart Disease
Daniel Levy, MD
JAMA. 2012;308(24):2624-2625. doi:10.1001/jama.2012.164971.
Editorial |  December 19, 2012
A Look Ahead at the Future of Diabetes Prevention and Treatment
David E. Arterburn, MD, MPH; Patrick J. O’Connor, MD, MA, MPH
JAMA. 2012;308(23):2517-2518. doi:10.1001/jama.2012.144749.
Review |  December 19, 2012 FREE
Association of Clopidogrel Pretreatment With Mortality, Cardiovascular Events, and Major Bleeding Among Patients Undergoing Percutaneous Coronary Intervention:  A Systematic Review and Meta-analysis
Anne Bellemain-Appaix, MD; Stephen A. O’Connor, MD; Johanne Silvain, MD, PhD; et al.
JAMA. 2012;308(23):2507-2516. doi:10.1001/jama.2012.50788.
INCLUDES: CME , Supplemental Content

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
RESEARCH LETTER  |  June 17, 2013
ω-3 Fatty Acid Supplements for Secondary Prevention of Cardiovascular Disease: From “No Proof of Effectiveness” to “Proof of No Effectiveness”
Andrea Messori, PharmD; Valeria Fadda, PharmD; Dario Maratea, PharmD; et al.
JAMA Internal Medicine
Editor's Correspondence  |  June 10, 2013
Noncommunicable Diseases in Developing Countries: Focus on Research Capacity Building
Ayodele Odutayo, BHSc; Naheed Hirji, BASc
JAMA Internal Medicine
Research Letters  |  May 13, 2013
Rapid Assessment of Cardiovascular Risk Among Users of Smoking Cessation Drugs Within the US Food and Drug Administration's Mini-Sentinel Program
Sengwee Toh, ScD; Meghan A. Baker, MD, ScD; Jeffrey S. Brown, PhD; et al.
JAMA Internal Medicine
Original Investigation  |  February 4, 2013
Dietary and Supplemental Calcium Intake and Cardiovascular Disease Mortality:  The National Institutes of Health–AARP Diet and Health Study
Qian Xiao, PhD; Rachel A. Murphy, PhD; Denise K. Houston, PhD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems